Foteini Theodorakakou Selected Research

Foteini Theodorakakou Research Topics

Disease

16	Multiple Myeloma 03/2024 - 12/2020
13	Immunoglobulin Light-chain Amyloidosis 11/2023 - 01/2020
5	Amyloidosis 10/2023 - 01/2020
4	COVID-19 09/2023 - 01/2021
4	Waldenstrom Macroglobulinemia (Macroglobulinemia) 02/2023 - 11/2021
3	Paraproteinemias (Monoclonal Gammopathy) 11/2022 - 12/2020
3	Residual Neoplasm 12/2021 - 01/2021
2	Thrombosis (Thrombus) 02/2024 - 01/2023
2	Infections 09/2023 - 01/2023
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 04/2023 - 03/2022
2	Aortic Valve Stenosis (Aortic Stenosis) 04/2023 - 03/2022
2	Monoclonal Gammopathy of Undetermined Significance 03/2023 - 11/2022
2	Neoplasms (Cancer) 02/2023 - 11/2022
2	Thrombotic Microangiopathies 01/2023 - 06/2022
1	Hemorrhage 02/2024
1	Thrombocytopenia (Thrombopenia) 11/2023
1	Fatigue 11/2023
1	Nausea 11/2023
1	Cardiomyopathies (Cardiomyopathy) 10/2023
1	Pain (Aches) 09/2023
1	Chromosome Aberrations (Chromosome Abnormalities) 08/2023
1	Ischemia 01/2023
1	Hemolytic Anemia 01/2023
1	Atypical Hemolytic Uremic Syndrome 01/2023
1	Heart Failure 09/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Plasma Cell Neoplasms 01/2021
1	POEMS Syndrome (Syndrome, POEMS) 01/2020
1	Transthyretin-Related Hereditary Amyloidosis 01/2020

Drug/Important Bio-Agent (IBA)

8	daratumumabIBA 01/2024 - 01/2020
5	belantamab mafodotinIBA 02/2024 - 01/2021
5	Dexamethasone (Maxidex)FDA LinkGeneric 02/2024 - 01/2020
5	Neutralizing AntibodiesIBA 09/2023 - 01/2021
5	BNT162 VaccineIBA 08/2022 - 01/2021
4	Lenalidomide (CC 5013)FDA Link 03/2024 - 01/2020
4	Monoclonal AntibodiesIBA 09/2023 - 01/2021
4	VaccinesIBA 09/2023 - 01/2021
3	Prealbumin (Transthyretin)IBA 10/2023 - 01/2022
3	Proteasome InhibitorsIBA 02/2023 - 06/2022
3	Nerve Growth Factor (NGF)IBA 12/2021 - 01/2021
3	Immunoglobulins (Immunoglobulin)IBA 10/2021 - 12/2020
2	CreatinineIBA 02/2024 - 03/2023
2	AntibodiesIBA 09/2023 - 01/2022
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 07/2023 - 08/2022
2	GadoliniumIBA 04/2023 - 03/2022
2	Proteins (Proteins, Gene)FDA Link 03/2023 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 03/2023 - 10/2021
2	carfilzomibIBA 01/2023 - 06/2022
2	Complement System Proteins (Complement)IBA 01/2023 - 06/2022
2	Amyloid (Amyloid Fibrils)IBA 01/2023 - 01/2020
2	ChAdOx1 nCoV-19IBA 11/2021 - 01/2021
1	AlbuminsIBA 02/2024
1	Immunomodulating AgentsIBA 01/2024
1	tafamidisIBA 10/2023
1	Messenger RNA (mRNA)IBA 09/2023
1	tixagevimabIBA 09/2023
1	cilgavimab and tixagevimab drug combinationIBA 09/2023
1	cilgavimabIBA 09/2023
1	B-Cell Maturation AntigenIBA 07/2023
1	venetoclaxIBA 03/2023
1	Ritonavir (Norvir)FDA Link 01/2023
1	FibrinIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	molnupiravirIBA 01/2023
1	nirmatrelvirIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 11/2022
1	DNA (Deoxyribonucleic Acid)IBA 11/2022
1	Immunoglobulin M (IgM)IBA 11/2022
1	pro-brain natriuretic peptide (1-76)IBA 09/2022
1	Clostridium perfringens epsilon-toxinIBA 09/2022
1	DiureticsIBA 09/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	Bortezomib (Velcade)FDA Link 12/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2021
1	Antisense RNA (Anti-Sense RNA)IBA 01/2020
1	Amyloidogenic ProteinsIBA 01/2020

Therapy/Procedure

13	Therapeutics 03/2024 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
1	Drug Tapering 11/2023
1	Hematopoietic Stem Cell Mobilization 09/2023
1	Stem Cell Transplantation 09/2023
1	Organ Transplantation 01/2020
1	Contraindications 01/2020
1	Kidney Transplantation 01/2020
1	Heart Transplantation (Grafting, Heart) 01/2020